[Clinical experiences with agomelatine. The inner ear has to be synchronized again].
D000081:Acetamides / Q000494:pharmacology / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002940:Circadian Rhythm / Q000187:drug effects*; D018849:Controlled Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy* / Q000503:physiopathology; D007758:Ear, Inner / Q000187:drug effects* / Q000502:physiology*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology / Q000627:therapeutic use*; D008550:Melatonin / Q000819:agonists; D009422:Nervous System Diseases / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D020280:Sertraline / Q000627:therapeutic use; D012893:Sleep Wake Disorders / Q000188:drug therapy* / Q000503:physiopathology; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D009281:Naphthalenes
D000081:Acetamides; D000928:Antidepressive Agents; D006993:Hypnotics and Sedatives; D008550:Melatonin; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline; D014149:Tranquilizing Agents; C084711:agomelatine; D009281:Naphthalenes